Low cost is possible thanks to a new partnership between Clinton Health Access Initiative (CHAI), MedAccess and SD Biosensor.
Every year, about 1.3 million women living with HIV become pregnant and just under a million pregnant women contract syphilis.
Despite the availability of affordable diagnostic and treatment tools, undiagnosed and untreated infections continue to affect the lives of many mothers and their children.
In accordance with WHO, then rapid tests are easy to use and can integrate and optimize services. They can also allow more countriesEliminate mother-to-child transmission of HIV and syphilis (EMTCT)…
For Meg Doherty, Director of the WHO Global Office for HIV, Hepatitis and STIs [Sexually transmitted disease] Programs, new prices – exciting development.
“This will help more countries introduce dual HIV / syphilis testing and accelerate progress towards EMTCT for both HIV and syphilis, and provide services to key populations where both infections are common,” she said.
Since 2019, WHO has been recommending the use of these tests. not only as a first line of antenatal care to help countries eliminate mother-to-child transmission, but also as a way to cut costs.
Today in the agencywere prequalified in three different dual rapid HIV / syphilis tests.
Many countries have adopted these guidelines and are implementing tests, especially in the African Region.
WHO estimates that over five million such tests were purchased by major donors and governments last year, and the number will continue to grow.
For example, Nigeria started a pilot program in 2019 and is now moving towards national implementation. Indeed, in the coming year, the country plans to distribute four million.
Yet despite some important advances, the global introduction of dual rapid HIV / syphilis tests in antenatal care is still far from ideal: only 23 percent of all countries reported national policies.